FT

Merck abandons bid to develop Covid-19 vaccine

After lacklustre results, company says it will shift focus to potential drugs to treat the disease

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button